論文・技術情報追加のお知らせ

①Disproportionality Analysis of Abemaciclib in the FDA Adverse Event Reporting System: A Real-World Post-Marketing Pharmacovigilance Assessment.

アベマシクリブの有害事象評価研究

対象DB：FAERS

②Seizures associated with antibiotics: A real-world disproportionality analysis of FAERS database.

抗生物質と発作の関連性評価研究

対象DB：FAERS

③Adverse events related to darolutamide treatment: analysis of "real life" data from EudraVigilance and the Food and Drug Administration database entries.

ダロルタミドに関連する有害事象評価研究

対象DB：FAERS、EudraVigilance

④Atypical femur fracture associated with common anti-osteoporosis drugs in FDA adverse event reporting system.

抗骨粗鬆症薬による非定型大腿骨骨折のリスク調査研究

対象DB：FAERS

⑤Neuropsychiatric adverse reactions in patients treated with denosumab: two case reports and a review of data from the FDA Adverse Event Reporting System (FAERS).

デノスマブ投与患者における精神、神経系の有害事象評価研究

対象DB：FAERS

⑥Urological complications after COVID 19 vaccine according to age, sex and manufacturer.

COVID-19ワクチン接種後における泌尿器系有害事象のリスク調査研究

対象DB：VAERS

⑦Disproportionality analysis on hypothyroidism with roxadustat using the japanese adverse drug event database.

HIF-PHIの甲状腺機能への影響調査研究

対象DB：JADER